Silvercrest Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,610
| Closed | -$911K | – | 872 |
|
|
2023
Q2 | $911K | Sell |
21,610
-1,439,961
| -99% | -$58.2M | 0.01% | 609 |
|
|
2023
Q1 | $52.1M | Buy |
1,461,571
+72,351
| +5% | +$2.63M | 0.4% | 96 |
|
|
2022
Q4 | $51M | Sell |
1,389,220
-147,050
| -10% | -$5.81M | 0.39% | 90 |
|
|
2022
Q3 | $72.4M | Sell |
1,536,270
-177,095
| -10% | -$11.4M | 0.6% | 56 |
|
|
2022
Q2 | $123M | Buy |
1,713,365
+136,713
| +9% | +$9.99M | 0.93% | 14 |
|
|
2022
Q1 | $128M | Buy |
1,576,652
+148,885
| +10% | +$12.6M | 0.83% | 26 |
|
|
2021
Q4 | $146M | Buy |
1,427,767
+1,186,001
| +491% | +$114M | 0.92% | 13 |
|
|
2021
Q3 | $21.1M | Sell |
241,766
-12,419
| -5% | -$1.12M | 0.14% | 178 |
|
|
2021
Q2 | $22.7M | Sell |
254,185
-3,763
| -1% | -$318K | 0.15% | 177 |
|
|
2021
Q1 | $19.6M | Buy |
257,948
+5,653
| +2% | +$426K | 0.13% | 186 |
|
|
2020
Q4 | $17.2M | Buy |
252,295
+5,168
| +2% | +$322K | 0.13% | 183 |
|
|
2020
Q3 | $13.1M | Buy |
247,127
+30,362
| +14% | +$1.81M | 0.11% | 191 |
|
|
2020
Q2 | $12.6M | Buy |
216,765
+13,860
| +7% | +$745K | 0.11% | 183 |
|
|
2020
Q1 | $8M | Buy |
202,905
+1,195
| +0.6% | +$69.9K | 0.09% | 217 |
|
|
2019
Q4 | $12M | Sell |
201,710
-5,016
| -2% | -$270K | 0.09% | 214 |
|
|
2019
Q3 | $11M | Buy |
206,726
+5,907
| +3% | +$303K | 0.09% | 213 |
|
|
2019
Q2 | $10.3M | Buy |
200,819
+7,584
| +4% | +$353K | 0.1% | 176 |
|
|
2019
Q1 | $10M | Sell |
193,235
-38,014
| -16% | -$1.84M | 0.1% | 174 |
|
|
2018
Q4 | $9.1M | Buy |
231,249
+8,355
| +4% | +$388K | 0.1% | 175 |
|
|
2018
Q3 | $11.5M | Buy |
222,894
+31,050
| +16% | +$1.52M | 0.1% | 172 |
|
|
2018
Q2 | $9M | Buy |
191,844
+4,276
| +2% | +$177K | 0.08% | 191 |
|
|
2018
Q1 | $6.66M | Buy |
187,568
+38,853
| +26% | +$1.52M | 0.06% | 208 |
|
|
2017
Q4 | $6.48M | Buy |
148,715
+7,707
| +5% | +$360K | 0.06% | 214 |
|
|
2017
Q3 | $7.38M | Sell |
141,008
-1,228,526
| -90% | -$68.5M | 0.07% | 197 |
|
|
2017
Q2 | $79.7M | Sell |
1,369,534
-372,762
| -21% | -$19.4M | 0.85% | 30 |
|
|
2017
Q1 | $79.9M | Buy |
1,742,296
+95,840
| +6% | +$4.77M | 0.86% | 31 |
|
|
2016
Q4 | $86.6M | Buy |
1,646,456
+84,523
| +5% | +$4.09M | 0.97% | 20 |
|
|
2016
Q3 | $69.6M | Buy |
1,561,933
+94,914
| +6% | +$4.12M | 0.84% | 33 |
|
|
2016
Q2 | $55.9M | Buy |
1,467,019
+299,588
| +26% | +$13.2M | 0.71% | 47 |
|
|
2016
Q1 | $48.1M | Buy |
1,167,431
+159,122
| +16% | +$6.56M | 0.66% | 59 |
|
|
2015
Q4 | $48.9M | Buy |
1,008,309
+159,895
| +19% | +$7.11M | 0.68% | 55 |
|
|
2015
Q3 | $33.9M | Buy |
848,414
+43,881
| +5% | +$1.92M | 0.52% | 84 |
|
|
2015
Q2 | $32.3M | Buy |
+804,533
| New | +$27.8M | 0.43% | 97 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Silvercrest Asset Management's SYNH Position: Q3 2023 in Review
Silvercrest Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 21,610 shares — an estimated $911K sold.
Silvercrest Asset Management first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $146M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Silvercrest Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Silvercrest Asset Management sold 21,610 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $911K.
- Silvercrest Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
- Silvercrest Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $146M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Silvercrest Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.